top of page

Pelvic inflammatory disease (PID)

DOWNLOAD PDF
DOWNLOAD WORD

(Note:

Pelvic inflammatory disease (PID) is usually the result of infection ascending from the endocervix causing endometritis, salpingitis, parametritis, oophoritis, tubo-ovarian abscess and/or pelvic peritonitis

C. trachomatis is the commonest identified cause accounting for 14-35% of cases whilst Gardnerella vaginalis, anaerobes and other organisms commonly found in the vagina may also be implicated

Mycoplasma genitalium has been associated with upper genital tract infection in women and is a very likely cause of PID.

Pathogen-negative PID is common

The insertion of an intrauterine device (IUD) increases the risk of developing PID but only for 4-6 weeks after insertion

The risk of PID is highest in women aged under 25 not using barrier contraception and with a history of a new sexual partner)


Questionnaire/history:

Lower abdominal pain (typically bilateral (but can be unilateral)?

Abnormal vaginal or cervical discharge (often purulent)?

Deep dyspareunia?

Abnormal vaginal bleeding (including postcoital bleeding, inter-menstrual bleeding and menorrhagia)?

Secondary dysmenorrhoea?

 

Past medical history?

Current medication?

Known drug allergies?

 

Examination:

Lower abdominal tenderness (usually bilateral)?

Adnexal tenderness on bimanual vaginal examination?

Tender mass (sometimes present)?

Cervical motion tenderness on bimanual vaginal examination?

Fever (> 38°C) in moderate to severe disease?

 

Differential diagnoses:

Ectopic pregnancy: Pregnancy should be excluded in all women suspected of having PID

Acute appendicitis: Nausea and vomiting (in most patients with appendicitis but only 50% of those with PID), cervical movement pain will occur in about a quarter of women with appendicitis)

Endometriosis: If pain cyclical and related to the menstrual cycle

Ovarian cyst complication (eg torsion or rupture): Symptoms often of sudden onset

Urinary tract infection: Often associated with dysuria and/or urinary frequency

Irritable bowel syndrome: Disturbance in bowel habit and persistence of symptoms over a prolonged time period are common

Acute bowel infection or diverticular disease can also cause lower abdominal pain usually in association with other gastrointestinal symptoms

 

Investigations:

Pregnancy test

Testing for gonorrhoea, C. trachomatis and M. genitalium in the lower genital tract is recommended since a positive result supports the diagnosis of PID and may alter subsequent therapy but the absence of infection at this site does not exclude PID

Local availability of M. genitalium testing currently varies but testing is strongly recommended

Consider bloods (ESR/CRP/WCC) (unspecific and usually only abnormal in moderate or severe PID)


Management:

Admission for IV antibiotics, further investigation and/or possible surgical intervention should be considered in the following situations:

- A surgical emergency cannot be excluded

- Lack of response to oral therapy

- Clinically severe disease

- Presence of a tubo-ovarian abscess - usually systemically unwell and/or have severe pelvic pain; an adnexal mass may be present

- Intolerance to oral therapy

- Pregnancy

 

Ideally, all women with suspected PID should be referred for same-day GUM assessment (if not being admitted) for full infection screening (including M. Genitalium) and contact tracing

 

Empirical antibiotics should be started as soon as possible but ideally, full STI screening should have been done before antibiotics started, however starting antibiotics is a priority and should not be delayed whilst awaiting an appointment/swab result

 

Outpatient therapy is effective for mild to moderate PID; regime options include:

IM ceftriaxone 500 mg stat followed by oral doxycycline 100 mg twice BD plus metronidazole 400mg BD for 14 days

Oral ofloxacin 400 mg BD plus oral metronidazole 400 mg BD for 14 days

Oral moxifloxacin 400 mg OD for 14 days (1st line for M. Genitalium PID)

Evidence for whether an IUD should be left in situ or removed in women presenting with PID is limited. In women with mild to moderate PID the IUD may be left in situ but a review should be performed after 48-72 hours and the IUD removed if significant clinical improvement has not occurred

 

Resource(s):

BASHH 2018

CKS 2022

PHE/NICE

TERMS & CONDITIONS
PRIVACY POLICY

© 2023 Clinical Templates. All Rights Reserved.

bottom of page